Skip to content

Prescribed Knee Brace Treatments for Osteoarthritis of the Knee (Knee OA)

Behandlingseffekter Med Avlastande knäortoser för Patienter Med knäartros En Retro-och Prospektiv Multicenterregisterstudie

Status
Enrolling by invitation
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04651673
Enrollment
1500
Registered
2020-12-03
Start date
2020-09-09
Completion date
2030-12-31
Last updated
2025-08-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis

Keywords

knee brace, conservative treatment

Brief summary

The study is a non-controlled retro- and prospective multi center patient registry study. Subjects will be given a study ID number assigned at first brace fitting after consenting to partake. Participants will be asked to fill in a questionnaire either in electronic or paper version at first fitting. Additional follow up questionnaires will be implemented at 4 weeks, 6 months and 1 year post initial brace fitting. After that period patients will be contacted every year, until brace termination/ knee surgery or death.

Detailed description

This is a noninterventional registry study pertaining to knee OA braces. There are no comparative devices or treatments. Subjects are expected to follow the recommendations of the brace subscriber and other health care professionals at any time independent of their continuation within the registry. Subjects will be enrolled at the clinic where their brace was prescribed or at the site where the brace was fitted. There is no formal end date for this data registry. A revisit to this protocol may be motivated after 5 years, to assess if longer follow up is required. For individual participants follow up will continue with annual questionnaires as long as the brace is in use. The questionnaires will be administered either through mail with a paper version, or through a link to an electronical version (ePRO). There is also a possibility of administrating the questionnaires as a phone guided interview, if that is a mean that serves the patient or clinics better. The planned follow-ups are at 4 weeks, 6 months, 1 year from brace prescription and then annually as long as participants are disposed as ongoing in the registry. The questionnaires contains question about pain, function, medication, general brace use and quality of life question.

Interventions

OTHERThis is a non interventional registry

All patients, at listed investigational sites, that get prescription for a knee orthosis indicated for Knee OA symptomatic treatment, get an invite to partake in the evaluation registry.

Sponsors

Region Skane
CollaboratorOTHER
Össur Iceland ehf
Lead SponsorINDUSTRY

Study design

Observational model
OTHER
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Patients that are prescribed knee brace for symptomatic treatment of knee OA from partaking clinics * Older than 18 years

Exclusion criteria

* Younger than 18 years * Not willing or able to sign informed consent, or not cognitive impairments preventing understanding of the questionnaires.

Design outcomes

Primary

MeasureTime frameDescription
Changes in QALY's6 months follow upEQ-5D-5L
Proportion of patients that are using the braces6 months follow upbrace usage, days per week
Change in Pain status compared to baseline6 months follow upKnee injury and Osteoarthritis Outcome Score (KOOS)-12
Change in Mobility compared to baseline6 months follow upKOOS-12
Proportion of patients that are still using the braces1 year follow upbrace usage, days per week
Sick leave after receiving the braces6 months follow upProportion of sick leave
Changes in reported quality of life6 months follow upKOOS-12

Other

MeasureTime frameDescription
The patients' satisfaction of the value/effectiveness of the brace6 months follow upNumeric Rating Scale (NRS) for satisfaction (0-10)

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026